Detalhe da pesquisa
1.
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.
Infect Dis Ther
; 13(1): 237-250, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102448
2.
Erratum: Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study - CORRIGENDUM.
Antimicrob Steward Healthc Epidemiol
; 3(1): e102, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37396195
3.
Evaluation of the characteristics of infection prevention and control programs and infection control committees in Brazilian hospitals: A countrywide cross-sectional study.
Antimicrob Steward Healthc Epidemiol
; 3(1): e79, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179767